ASCI Flagged 50 Ad Campaigns By Ayurvedic, Homeopathic Drug Makers Offering 'COVID-19 Cure' in April

The disclosure comes a day after the government issued a gag order against Baba Ramdev’s company Patanjali Ayurved from advertising a drug as COVID-19 cure.

Mumbai: The Advertising Standards Council of India (ASCI) said it found 50 campaigns by ayurvedic and homeopathic drug makers offering a cure for COVID-19 in April alone and had flagged them to the union government for action.

The advertisements were across media platforms and were found to be violating Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) order dated April 1, 2020, prohibiting publicity and advertisement of AYUSH-related claims, the self-regulatory body said in a statement.

The disclosure from ASCI for April comes a day after the government issued a gag order against Baba Ramdev’s company Patanjali Ayurved from advertising a drug as COVID-19 cure within hours of him launching it.

ASCI said the AYUSH Ministry had sought its help to alert them about such advertisements and that it launched a drive to act against such misleading advertisements claiming prevention or cure for COVID-19.

The body also made public the list of the 50 companies found advertising the COVID-19 cure or prevention in April.

The list also includes a slew of entities advertising homeopathic medicine Arsenic Album 30, which is being used widely as a COVID-19 prevention drug.

No big brands featured on the list.

The ASCI said it also flagged 91 cases of a potential violation of Drugs and Magic Remedies regulations to the AYUSH Ministry. The list had companies claiming a cure for diabetes, cancer, sexual problems, lifestyle ailments like blood pressure and hypertension.

Also Read: With New ‘Cure’ for COVID-19, Patanjali Continues to Do ‘Science’ by Press Release

Misleading by omission

Meanwhile, Hindustan Unilever’s advertisement for its brand ‘Fair and Lovely’ Advanced Multi Vitamin has also faced ASCI flak for misleading by omission.

ASCI received a complaint against the brand and found that the print advertisement showing image enhancement effects such as brightening/lightening was misleading. The advertiser, while admitting to using minor image enhancement, did not specify the image enhancement done by them.

Other major brands which have faced the ASCI’s flak during April include Asian Paints, Reliance Industries, Tata Motors, FCA India Automobiles, Grofers, Makemytrip and Indigo Airlines for various concerns.

Celebrities who were found to have not done due diligence in advertisements making misleading claims included actors Sachin and Supriya Pilgaonkar for their ad for Tirumalla Oil, badminton player Saina Nehwal’s campaign for Rasna and actor Parineeti Chopra for Bajaj Consumer Care, it said.

ASCI investigated complaints against 533 advertisements, of which 115 advertisements were promptly withdrawn while evaluation of the remaining 418 advertisements led to complaints against 377 being upheld, it said.